These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2471199)

  • 1. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
    Matsukura M; Zon G; Shinozuka K; Robert-Guroff M; Shimada T; Stein CA; Mitsuya H; Wong-Staal F; Cohen JS; Broder S
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4244-8. PubMed ID: 2471199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
    Li G; Lisziewicz J; Sun D; Zon G; Daefler S; Wong-Staal F; Gallo RC; Klotman ME
    J Virol; 1993 Nov; 67(11):6882-8. PubMed ID: 8411393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
    Anazodo MI; Wainberg MA; Friesen AD; Wright JA
    J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Malim MH; Hauber J; Le SY; Maizel JV; Cullen BR
    Nature; 1989 Mar; 338(6212):254-7. PubMed ID: 2784194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
    Bevec D; Dobrovnik M; Hauber J; Böhnlein E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.
    Zelphati O; Zon G; Leserman L
    Antisense Res Dev; 1993; 3(4):323-38. PubMed ID: 8155974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
    Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H
    Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
    Felber BK; Hadzopoulou-Cladaras M; Cladaras C; Copeland T; Pavlakis GN
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1495-9. PubMed ID: 2784208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
    Lund OS; Nielsen JO; Hansen JE
    Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.
    Agrawal S; Ikeuchi T; Sun D; Sarin PS; Konopka A; Maizel J; Zamecnik PC
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7790-4. PubMed ID: 2682627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.
    Anazodo MI; Salomon H; Friesen AD; Wainberg MA; Wright JA
    Gene; 1995 Dec; 166(2):227-32. PubMed ID: 8543166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.
    Dayton AI; Terwilliger EF; Potz J; Kowalski M; Sodroski JG; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1988; 1(5):441-52. PubMed ID: 2851651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
    Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
    Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro anti-HIV activity of phosphorothioate alpha-anomeric oligodeoxynucleotides].
    Rayner B; Matsukura M; Morvan F; Cohen JS; Imbach JL
    C R Acad Sci III; 1989; 310(3):61-4. PubMed ID: 2516764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of simian immunodeficiency virus regulatory genes.
    Colombini S; Arya SK; Reitz MS; Jagodzinski L; Beaver B; Wong-Staal F
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4813-7. PubMed ID: 2544874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
    Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligodeoxynucleotide: inhibitor of splicing of mRNA of human immunodeficiency virus.
    Daum T; Engels JW; Mag M; Muth J; Lücking S; Schröder HC; Matthes E; Müller WE
    Intervirology; 1992; 33(2):65-75. PubMed ID: 1568836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication by targeting the Rev protein.
    Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
    Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.